#BEGIN_DRUGCARD DB00017

# AHFS_Codes:
68:24.00

# ATC_Codes:
H05BA01

# Absorption:
Salmon calcitonin is rapidly absorbed and eliminated. Bioavailability following subcutaneous and intramuscular injection in humans is high and similar for the two routes of administration (71% and 66%, respectively).

# Biotransformation:
Salmon calcitonin is primarily and almost exclusively degraded in the kidneys, forming pharmacologically inactive fragments of the molecule.

# Brand_Mixtures:
Not Available

# Brand_Names:
Calcimar
Miacalcin (Novartis)

# CAS_Registry_Number:
47931-85-1

# ChEBI_ID:
Not Available

# Chemical_Formula:
C145H240N44O48S2

# Chemical_IUPAC_Name:
Not Available

# Chemical_Structure:
>DB00017 sequence
CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Synthetic peptide, 32 residues long formulated as a nasal spray.

# Dosage_Forms:
Liquid	Intramuscular
Liquid	Nasal
Solution	Intramuscular
Solution	Nasal

# Drug_Category:
Antihypercalcemic agent
Antiosteporotic Agents
Bone Density Conservation Agents

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Approved
Biotech
Investigational

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
-0.537

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Y00765

# Generic_Name:
Salmon Calcitonin

# HET_ID:
Not Available

# Half_Life:
50-80 minutes

# InChI_Identifier:
Not Available

# InChI_Key:
Not Available

# Indication:
For the treatment of post-menopausal osteoporosis

# KEGG_Compound_ID:
C06865

# KEGG_Drug_ID:
D00249

# LIMS_Drug_ID:
17

# Mechanism_Of_Action:
Calcitonin binds to the calcitonin receptor (found primarily in osteoclasts) which then enhances the production of vitamin D producing enzymes (25-hydroxyvitamine D-24-hydroxylase), leading to greater calcium retention and enhanced bone density. Binding of calcitonin to its receptor also activates adenylyl cyclase and the phosphatidyl-inositol-calcium pathway.

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
3431.8530

# Molecular_Weight_Mono:
Not Available

# Organisms_Affected:
Humans and other mammals

# PDB_Experimental_ID:
1BYV

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
PA448715

# Pharmacology:
Calcitonin inhibits bone removal by osteoclasts (bone remodeling cells) and promotes bone formation by osteoblasts. This leads to a net increase in bone mass. Calcitonin also reduces plasma calcium levels and enhances secretion of ions in the kidney.

# Predicted_LogP_Hydrophobicity:
Not Available

# Predicted_LogS:
Not Available

# Predicted_Water_Solubility:
Not Available

# Primary_Accession_No:
DB00017

# Protein_Binding:
30 to 40%

# PubChem_Compound_ID:
Not Available

# PubChem_Substance_ID:
Not Available

# RxList_Link:
http://www.rxlist.com/cgi/generic2/calcit.htm

# Salts:
Not Available

# Secondary_Accession_No:
BIOD00025
BTD00025

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
Not Available

# State:
liquid

# Structure:
0

# SwissProt_ID:
P01263

# SwissProt_Name:
CALC1_ONCKE

# Synonyms:
Calcitonin 1 precursor
Calcitonin, salmon
Calcitonin-salmon
Salmotonin

# Synthesis_Reference:
Not Available

# Toxicity:
Salmon calcitonin is devoid of embryotoxic, teratogenic and mutagenic potential.

# Update_Date:
2013-02-07 10:33:03 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Calcitonin

# pKa_Isoelectric_Point:
8.86

# Drug_Target_1_Cellular_Location:
Membrane
multi-pass membrane protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
11752352	Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
3004987	Bouizar Z, Fouchereau-Peron M, Taboulet J, Moukhtar MS, Milhaud G: Purification and characterization of calcitonin receptors in rat kidney membranes by covalent cross-linking techniques. Eur J Biochem. 1986 Feb 17;155(1):141-7.
7610922	Stroop SD, Moore EE: Intracellular calcium increases mediated by a recombinant human calcitonin receptor. J Bone Miner Res. 1995 Apr;10(4):524-32.
9231703	Sarkar A, Dickerson IM: Cloning, characterization, and expression of a calcitonin receptor from guinea pig brain. J Neurochem. 1997 Aug;69(2):455-64.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
CALCR

# Drug_Target_1_GenBank_ID_Gene:
L00587

# Drug_Target_1_GenBank_ID_Protein:
179880

# Drug_Target_1_GeneCard_ID:
CALCR

# Drug_Target_1_Gene_Name:
CALCR

# Drug_Target_1_Gene_Sequence:
>1473 bp
ATGAGGTTCACATTTACAAGCCGGTGCTTGGCACTGTTTCTTCTTCTAAATCACCCAACC
CCAATTCTTCCTGCCTTTTCAAATCAAACCTATCCAACAATAGAGCCCAAGCCATTTCTT
TACGTCGTAGGACGAAAGAAGATGATGGATGCACAGTACAAATGCTATGACCGAATGCAG
CAGTTACCCGCATACCAAGGAGAAGGTCCATATTGCAATCGCACCTGGGATGGATGGCTG
TGCTGGGATGACACACCGGCTGGAGTATTGTCCTATCAGTTCTGCCCAGATTATTTTCCG
GATTTTGATCCATCAGAAAAGGTTACAAAATACTGTGATGAAAAAGGTGTTTGGTTTAAA
CATCCTGAAAACAATCGAACCTGGTCCAACTATACTATGTGCAATGCTTTCACTCCTGAG
AAACTGAAGAATGCATATGTTCTGTACTATTTGGCTATTGTGGGTCATTCTTTGTCAATT
TTCACCCTAGTGATTTCCCTGGGGATTTTCGTGTTTTTCAGAAAATTGACAACTATTTTT
CCTTTGAATTGGAAATATAGGAAGGCATTGAGCCTTGGCTGCCAAAGGGTAACCCTGCAC
AAGAACATGTTTCTTACTTACATTCTGAATTCTATGATTATCATCATCCACCTGGTTGAA
GTAGTACCCAATGGAGAGCTCGTGCGAAGGGACCCGGTGAGCTGCAAGATTTTGCATTTT
TTCCACCAGTACATGATGGCCTGCAACTATTTCTGGATGCTCTGTGAAGGGATCTATCTT
CATACACTCATTGTCGTGGCTGTGTTTACTGAGAAGCAACGCTTGCGGTGGTATTATCTC
TTGGGCTGGGGGTTCCCGCTGGTGCCAACCACTATCCATGCTATTACCAGGGCCGTGTAC
TTCAATGACAACTGCTGGCTGAGTGTGGAAACCCATTTGCTTTACATAATCCATGGACCT
GTCATGGCGGCACTTGTGGTCAATTTCTTCTTTTTGCTCAACATTGTCCGGGTGCTTGTG
ACCAAAATGAGGGAAACCCATGAGGCGGAATCCCACATGTACCTGAAGGCTGTGAAGGCC
ACCATGATCCTTGTGCCCCTGCTGGGAATCCAGTTTGTCGTCTTTCCCTGGAGACCTTCC
AACAAGATGCTTGGGAAGATATATGATTACGTGATGCACTCTCTGATTCATTTCCAGGGC
TTCTTTGTTGCGACCATCTACTGCTTCTGCAACAATGAGGTCCAAACCACCGTGAAGCGC
CAATGGGCCCAATTCAAAATTCAGTGGAACCAGCGTTGGGGGAGGCGCCCCTCCAACCGC
TCTGCTCGCGCTGCAGCCGCTGCTGCGGAGGCTGGCGACATCCCAATTTACATCTGCCAT
CAGGAGCCGAGGAATGAACCAGCCAACAACCAAGGCGAGGAGAGTGCTGAGATCATCCCT
TTGAATATCATAGAGCAAGAGTCATCTGCTTGA

# Drug_Target_1_General_Function:
Involved in calcitonin receptor activity

# Drug_Target_1_General_References:
10570950	Nishikawa T, Ishikawa H, Yamamoto S, Koshihara Y: A novel calcitonin receptor gene in human osteoclasts from normal bone marrow. FEBS Lett. 1999 Sep 24;458(3):409-14.
12853948	Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64.
1331173	Gorn AH, Lin HY, Yamin M, Auron PE, Flannery MR, Tapp DR, Manning CA, Lodish HF, Krane SM, Goldring SR: Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line. J Clin Invest. 1992 Nov;90(5):1726-35.
7588285	Albrandt K, Brady EM, Moore CX, Mull E, Sierzega ME, Beaumont K: Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene. Endocrinology. 1995 Dec;136(12):5377-84.
7720653	Nussenzveig DR, Mathew S, Gershengorn MC: Alternative splicing of a 48-nucleotide exon generates two isoforms of the human calcitonin receptor. Endocrinology. 1995 May;136(5):2047-51.
7733946	Nakamura M, Hashimoto T, Nakajima T, Ichii S, Furuyama J, Ishihara Y, Kakudo K: A new type of human calcitonin receptor isoform generated by alternative splicing. Biochem Biophys Res Commun. 1995 Apr 17;209(2):744-51.
8078488	Kuestner RE, Elrod RD, Grant FJ, Hagen FS, Kuijper JL, Matthewes SL, O'Hara PJ, Sheppard PO, Stroop SD, Thompson DL, et al.: Cloning and characterization of an abundant subtype of the human calcitonin receptor. Mol Pharmacol. 1994 Aug;46(2):246-55.
8143880	Frendo JL, Pichaud F, Mourroux RD, Bouizar Z, Segond N, Moukhtar MS, Jullienne A: An isoform of the human calcitonin receptor is expressed in TT cells and in medullary carcinoma of the thyroid. FEBS Lett. 1994 Apr 4;342(2):214-6.
9817931	Taboulet J, Frenkian M, Frendo JL, Feingold N, Jullienne A, de Vernejoul MC: Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women. Hum Mol Genet. 1998 Dec;7(13):2129-33.

# Drug_Target_1_HGNC_ID:
HGNC:1440

# Drug_Target_1_HPRD_ID:
00239

# Drug_Target_1_ID:
479

# Drug_Target_1_Locus:
7q21.3

# Drug_Target_1_Molecular_Weight:
57304

# Drug_Target_1_Name:
Calcitonin receptor

# Drug_Target_1_Number_of_Residues:
490

# Drug_Target_1_PDB_ID:
Not Available

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00002	7tm_2
PF02793	HRM

# Drug_Target_1_Protein_Sequence:
>Calcitonin receptor precursor
MRFTFTSRCLALFLLLNHPTPILPAFSNQTYPTIEPKPFLYVVGRKKMMDAQYKCYDRMQ
QLPAYQGEGPYCNRTWDGWLCWDDTPAGVLSYQFCPDYFPDFDPSEKVTKYCDEKGVWFK
HPENNRTWSNYTMCNAFTPEKLKNAYVLYYLAIVGHSLSIFTLVISLGIFVFFRKLTTIF
PLNWKYRKALSLGCQRVTLHKNMFLTYILNSMIIIIHLVEVVPNGELVRRDPVSCKILHF
FHQYMMACNYFWMLCEGIYLHTLIVVAVFTEKQRLRWYYLLGWGFPLVPTTIHAITRAVY
FNDNCWLSVETHLLYIIHGPVMAALVVNFFFLLNIVRVLVTKMRETHEAESHMYLKAVKA
TMILVPLLGIQFVVFPWRPSNKMLGKIYDYVMHSLIHFQGFFVATIYCFCNNEVQTTVKR
QWAQFKIQWNQRWGRRPSNRSARAAAAAAEAGDIPIYICHQEPRNEPANNQGEESAEIIP
LNIIEQESSA

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-24

# Drug_Target_1_Specific_Function:
This is a receptor for calcitonin. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. The calcitonin receptor is thought to couple to the heterotrimeric guanosine triphosphate-binding protein that is sensitive to cholera toxin

# Drug_Target_1_SwissProt_ID:
P30988

# Drug_Target_1_SwissProt_Name:
CALCR_HUMAN

# Drug_Target_1_Synonyms:
CT-R
Calcitonin receptor precursor

# Drug_Target_1_Theoretical_pI:
8.71

# Drug_Target_1_Transmembrane_Regions:
154-173
197-216
237-259
277-296
313-336
360-377
390-411

#END_DRUGCARD DB00017
